Neill W. Clark

Mr. Clark is Of Counsel for Faruqi and Faruqi, LLP’s Pennsylvania office.  Before joining the firm, Mr. Clark was an associate at Berger & Montague, P.C. where he was significantly involved in prosecuting antitrust class actions on behalf of direct purchasers of brand name drugs and charging pharmaceutical manufacturers with illegally blocking the market entry of less expensive competitors.

Eight of those cases have resulted in substantial settlements totaling over $950 million: In re Cardizem CD Antitrust Litig. settled in November 2002 for $110 million; In re Buspirone Antitrust Litig. settled in April 2003 for $220 million; In re Relafen Antitrust Litig. settled in  February 2004 for $175 million; In re Platinol Antitrust Litig. settled in November 2004 for $50 million; In re Terazosin Antitrust Litig. settled in April 2005 for $75 million; In re Remeron Antitrust Litig. settled in November 2005 for $75 million; In re Ovcon Antitrust Litig. settled in 2009 for $22 million; and In re Tricor Direct Purchaser Antitrust Litig. settled in April 2009 for $250 million.

Mr. Clark was also principally involved in a case alleging a conspiracy among hospitals and the Arizona Hospital and Healthcare Association to depress the compensation of per diem and traveling nurses, Johnson et al. v. Arizona Hospital and Healthcare Association et al., No. CV07-1292 (D. Ariz.).

Mr. Clark was selected as a “Rising Star” by Pennsylvania Super Lawyers and listed as one of the Top Young Lawyers in Pennsylvania in the December 2005 edition of Philadelphia Magazine.  Two cases in which he has been significantly involved have been featured as “Noteworthy Cases” in the NATIONAL LAW JOURNAL articles, “The Plaintiffs’ Hot List” (In re Tricor Antitrust Litig. October 5, 2009 and Johnson v. Arizona Hosp. and Healthcare Ass’n., October 3, 2011).

Mr. Clark graduated cum laude from Appalachian State University in 1994 and from Temple University Beasley School of Law in 1998, where he earned seven “distinguished class performance” awards, an oral advocacy award and a “best paper” award.